{"resourceType":"ValueSet","id":"canshare-who-endo-neuroendo-adrenal-medulla-primary-histology","meta":{"versionId":"1","lastUpdated":"2024-11-05T17:09:43.293+13:00"},"language":"en-x-sctlang-23162100-0210105","url":"https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-endo-neuroendo-adrenal-medulla-primary-histology","identifier":[{"system":"http://canshare.co.nz/fhir/NamingSystem/valuesets","value":"canshare-who-endo-neuroendo-adrenal-medulla-primary-histology"}],"version":"20241030","name":"canshare-who-endo-neuroendo-adrenal-medulla-primary-histology","title":"NZ WHO endocrine and neuroendocrine adrenal medulla primary histology","status":"active","experimental":false,"date":"2024-10-30","publisher":"Te Aho o Te Kahu","contact":[{"telecom":[{"system":"email","value":"info@teaho.govt.nz"}]}],"description":"Histologies used for endocrine and Neuroendocrine adrenal medulla cancer types (WHO Classification of Tumours, Endocrine and Neuroendocrine Tumours, latest edition) 6. Adrenal medulla and extra-adrenal paraganglia tumours (excluding paraganglioma) 8. Neuroendocrine neoplasms in non-endocrine organs excluding benign neoplasms or an 'Other' value.","compose":{"include":[{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/21000210109","filter":[{"property":"constraint","op":"=","value":"(^380961000210101 |New Zealand World Health Organization classification of tumors 5th edition endocrine and neuroendocrine adrenal medulla and extra-adrenal paraganglia histology reference set (foundation metadata concept)| OR 74964007 |Other|) MINUS ( ^467171000210104 |New Zealand World Health Organization classification of tumors 5th edition endocrine and neuroendocrine benign histology reference set (foundation metadata concept)| OR 31794002 |Sympathetic paraganglioma| OR 52205002 |Parasympathetic paraganglioma| OR 817953005 |Composite paraganglioma| OR 430101000210103 |Composite paraganglioma-ganglioneuroma| OR 430111000210101 |Composite paraganglioma-ganglioneuroblastoma| OR 430121000210106 |Composite paraganglioma-neuroblastoma|)"}]}]},"expansion":{"identifier":"f03a081d-cd65-4cb8-9799-5ab0819f60a7","timestamp":"2024-11-11T13:48:46+13:00","total":10,"offset":0,"parameter":[{"name":"version","valueUri":"http://snomed.info/sct|http://snomed.info/sct/21000210109/version/20241001"},{"name":"count","valueInteger":2147483647},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://snomed.info/sct","code":"817952000","display":"Composite phaeochromocytoma"},{"system":"http://snomed.info/sct","code":"430071000210106","display":"Composite phaeochromocytoma and ganglioneuroblastoma"},{"system":"http://snomed.info/sct","code":"430061000210100","display":"Composite phaeochromocytoma and ganglioneuroma"},{"system":"http://snomed.info/sct","code":"430091000210105","display":"Composite phaeochromocytoma and malignant peripheral nerve sheath tumour"},{"system":"http://snomed.info/sct","code":"430081000210108","display":"Composite phaeochromocytoma and neuroblastoma"},{"system":"http://snomed.info/sct","code":"822951003","display":"Intermixed ganglioneuroblastoma"},{"system":"http://snomed.info/sct","code":"29370006","display":"Malignant phaeochromocytoma"},{"system":"http://snomed.info/sct","code":"87364003","display":"Neuroblastoma"},{"system":"http://snomed.info/sct","code":"822950002","display":"Nodular ganglioneuroblastoma"},{"system":"http://snomed.info/sct","code":"74964007","display":"Other"}]}}